Searched for
CLINICAL DEVELOPMENT
AI-based drug developer Basecamp valued at $800 million after $140 million funding roundThe oversubscribed round was led by S32, with participation from Nvidia, Anthropic's Anthology Fund, Catalio Capital Management, the NATO I...- Anthropic, OpenEvidence partner to bring medical AI worldwideOpenEvidence answers doctors' questions by drawing on peer-reviewed medical research and treatment guidelines. The platform is free to clin...
- Celldex shares slip 15% as safety concerns cloud skin drug trial win(Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tue...
- Quote of the day by Sigmund Freud: 'If his lips are silent, he chatters with his fingertips, betrayal oozes out of him at every pore' - Founder of psychoanalysis on human behaviourSigmund Freud’s striking observation on human behaviour suggests that people may struggle to completely hide their secrets. He wrote that e...
- Grok 4.7: What’s new in SpaceXAI’s latest model and why it mattersElon Musk’s AI company SpaceXAI has launched Grok 4.7, its latest model focused on coding and knowledge work. The company says the model is...
- Ichor Biologics seeks $80-100 million PE funding for minority stake saleIchor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...
- Biocon arm gets positive EMA panel recommendation for breast cancerbiosimilar PebrilzoBiocon Biologics has received a positive recommendation from the European Medicines Agency’s CHMP for its Pertuzumab biosimilar, Pebrilzo, ...
- Aragen steps up investment in complex drug modalities; plans 500 KL new CDMO capacityAragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-mol...
- Sunset years, rising prices: Coimbatore's senior-living villas ride India's retirement boomCoimbatore is now India's leading senior-living destination, attracting retirees from major cities. This southern city offers pleasant weat...
- ENTOD Pharmaceuticals secures patent for its insulin eye dropCurrently at the pre-clinical stage of development, the patented insulin eye drops are being investigated as a potential novel therapeutic ...
- Doctor says 80% of patients suffering from autoimmune disorders share four characteristics: ‘They feel responsible for others…’Women are disproportionately affected by autoimmune disorders, which are chronic and incurable conditions. According to conservative estima...
- Anthropic quietly sets up biology lab as it ramps AI drug programAt a time when fears of AI are gripping the public, the startup has built a wet lab, or place for physical experiments, in the San Francisc...
- Kim Kardashian has esophagitis: What is it, when to see the doctor, and how is it different from esophageal cancer that killed her father?Kim Kardashian revealed her esophagitis diagnosis during a reality show trailer. This condition involves inflammation of the esophagus, whi...
- ET Startup Awards 2026: Theranautilus’ nanorobots will be ready for human trials by year-endTheranautilus won the Top Innovator category at The Economic Times Startup Awards 2026 for its unique nanorobot technology, which is built ...
- QDENGA dengue vaccine to hit India market in 2027; Dr Reddy’s to sell itIndia's first approved dengue vaccine, QDENGA, will launch in the private market by mid-2027. Dr Reddy's Laboratories will distribute and p...
- NDude Labs invests in nutraceutical ingredients firm NutriventiaThe investment will help Nutriventia strengthen its research and development pipeline, expand its global commercial presence and scale its ...
- Dr Reddy's inks pact with Gilead for once-yearly HIV prevention drug lenacapavirDr Reddy's Laboratories and Gilead Sciences have signed a licensing agreement. This pact involves investigational once-yearly lenacapavir f...
- TRUE ARTIS raises Rs 11.4 crore to expand network of premium aesthetic surgery centresSeed round led by Zeropearl VC will support two new centres in Delhi NCR, expansion of specialist teams and technology-led patient care
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Does smoking protect against Parkinson’s? A study of half a million people points to carbon monoxide, revealing a surprising clue in cigarette smokeA recent study indicates that carbon monoxide might be responsible for lowering the risk of Parkinson's disease, as opposed to nicotine. Re...
Load More
